3
Announcements
Trials
Browse
Landscape
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
18
Observational
1
Sponsor
Cancer Type
Head & Neck
1
Conditions
Small Cell Lung Carcinoma
4
Lung Neoplasms
4
Carcinoma, Non-Small-Cell Lung
4
Unresectable Hepatocellular Carcinoma
1
Squamous Cell Carcinoma of Head and Neck
1
Sarcopenia
1
Recurrent Squamous Cell Lung Carcinoma
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Oropharyngeal Neoplasms
1
Non-Small Cell Lung Cancer NSCLC
1
Neoplasms
1
Melanoma
1
Kidney Neoplasms
1
Hepatobiliary Cancers
1
Head and Neck Neoplasms
1
Deglutition Disorders
1
Interventions
Surveys and Questionnaires
26
Blood Specimen Collection
19
Radiotherapy
17
Gene Expression Profiling
11
Immunohistochemistry
9
Cetuximab
6
Polymerase Chain Reaction
5
Nivolumab
5
Immunotherapy
5
Cisplatin
5
Microarray Analysis
4
Drug Therapy
4
Biopsy
4
pembrolizumab
3
Tissue Banks
3
Therapeutics
3
Reverse Transcriptase Polymerase Chain Reaction
3
Restraint, Physical
3
Radiotherapy, Intensity-Modulated
3
Radiation
3
Observation
3
Interviews as Topic
3
Immunologic Techniques
3
Immunoenzyme Techniques
3
Flow Cytometry
3
Chemotherapy, Adjuvant
3
Surgical Procedures, Operative
2
Quality of Life
2
Psychiatric Rehabilitation
2
Physical Therapy Modalities
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Head and Neck Neoplasms
×
durvalumab
×
Clear all
NCT04359199
2023-02-10
QUASAR
University of California, San Diego
Unknown
42 enrolled